Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 70

Sort by

Sort Order Select

Journal Articles

Impact-AML: A European Master Framework for Cohort Studies and Pragmatic Clinical Trials in Relapse or Refractory Acute Myeloid Leukemia

Blood (2023) 142 (Supplement 1): 1533.

https://doi.org/10.1182/blood-2023-184745

Published: 2023

Journal Articles

Impact of Age on Outcome in Newly Diagnosed Multiple Myeloma Patients Undergoing Upfront Autologous Hematopoietic Cell Transplantation from the Worldwide Network for Blood and Marrow Transplantation Global Study

Blood (2023) 142 (Supplement 1): 785.

https://doi.org/10.1182/blood-2023-179153

Published: 2023

Journal Articles

Help for Ukrainian Hematology Patients (HUP) - a Global Initiative Supporting the Establishment of Hematology Centers and Hematopoietic Cell Transplantation Programs in a Time of War

Blood (2023) 142 (Supplement 1): 264.

https://doi.org/10.1182/blood-2023-185883

Published: 2023

Journal Articles

Changes in Cardiovascular Magnetic Resonanse T1 and T2 Mapping in Patients Undergoing Autologous Hematopoietic Stem Cell Transplantation

Audrone Vaitiekiene, Migle Kulboke, Monika Bieseviciene, Antanas Jankauskas, Igne Strazdiene, Emilija Lidziute, Darija Jankauskaite, Ignas Gaidamavicius, Rolandas Gerbutavicius, Jolanta Justina Vaskelyte, Domas Vaitiekus, Gintare Sakalyte, Dietger W. Niederwieser

Blood (2023) 142 (Supplement 1): 7077.

https://doi.org/10.1182/blood-2023-187809

Published: 2023

Journal Articles

MiR-143 Targets ERK5 in Granulopoiesis and Predicts Outcome of Patients with Acute Myeloid Leukemia

Jens-Uwe Hartmann, MSc, Daniela Bräuer-Hartmann, PhD, Miroslava Kardosova, MSc, Franziska Wilke, MSc, Alexander Arthur Wurm, PhD, Cindy Schoedel, MD, Dennis Gerloff, PhD, Christiane Katzerke, PhD, Rosanna H.E. Krakowsky, MSc, Carolina Yaeko Namasu, MSc, Marius Bill, Sebastian Schwind, MD, Carsten Müller-Tidow, Dietger W. Niederwieser, MD, Meritxell Alberich-Jorda, Gerhard Behre, MD

Blood (2017) 130 (Supplement 1): 3950.

https://doi.org/10.1182/blood.V130.Suppl_1.3950.3950

Published: 2017

Journal Articles

Life Expectancy in Long-Term Survivors Transplanted for Myelofibrosis: A Registry Study from the Chronic Malignancies Working Party of the European Society for Blood and Marrow Transplantation

Blood (2017) 130 (Supplement 1): 3307.

https://doi.org/10.1182/blood.V130.Suppl_1.3307.3307

Published: 2017

Journal Articles

Long-Term Outcome of Allogeneic Stem Cell Transplantation (allo-SCT) in Patients with Waldenstrom Macroglobulinemia (WM)-a Retrospective Study of the Lymphoma Working Party of the European Society for Blood and Marrow Transplantation (EBMT)

Charalampia Kyriakou, Ariane Boumendil, PhD, Herve Finel, Norbert Schmitz, MD, PhD, Henrik Sengeloev, MD, Stephen Mackinnon, MD, Didier Blaise, MD PhD, Patrice Chevallier, MD PhD, Paul Browne, MD, Charles Craddock, MD PhD, Dietger W. Niederwieser, MD, Johannes Schetelig, MD PhD, Stig Lenhoff, Nathalie Fegueux, MD, Silvia Montoto, MD, Peter Dreger, MD PhD

Blood (2016) 128 (22): 4661.

https://doi.org/10.1182/blood.V128.22.4661.4661

Published: 2016

Journal Articles

Randomized Controlled Trial of Two Different Dosing Regimens of Palifermin to Prevent Mucositis In Multiple Myeloma Patients Receiving One-Day Administration of High-Dose Melphalan

Nicole M.A. Blijlevens, MD, PhD, Maarten E de Chateau, MD, PhD, Gergely Krivan, MD, Werner Rabitsch, MD, Arpad Szomor, MD, Robert Pytlik, MD, Agneta Lissmats, PhD, Hans Erik Johnsen, MD, Tapani Ruutu, MD, Hermann Einsele, MD, Dietger W Niederwieser, MD

Blood (2010) 116 (21): 904.

https://doi.org/10.1182/blood.V116.21.904.904

Published: 2010

Journal Articles

Outcomes Following Relapse of Non-Hodgkin Lymphoma (NHL) or Chronic Lymphocytic Leukemia (CLL) After Nonmyeloablative Conditioning and Allogeneic Hematopoietic Cell Transplantation (HCT) From HLA-Matched Related or Unrelated Donors

Blood (2010) 116 (21): 1292.

https://doi.org/10.1182/blood.V116.21.1292.1292

Published: 2010

Journal Articles

Allogeneic and Autologous Transplantation In Patients with Aggressive B- and T-Cell Lymphomas

Frank Schueler, MD, Madelaine Hoffmann, Christian Pfrepper, Said Daneschnejad, Thoralf Lange, MD, Wolfram Pönisch, Haifa K. Al-Ali, Dietger W Niederwieser, MD, Nadezda Basara, MD

Blood (2010) 116 (21): 3544.

https://doi.org/10.1182/blood.V116.21.3544.3544

Published: 2010

Journal Articles

Safety of Defibrotide (DF) In Stem Cell Transplant (SCT) Patients (Pts).

Selim Corbacioglu, MD, Enric Carreras, MD, PhD, Dietger W Niederwieser, MD, Marco Sardella, PharmD, Margaret Hoyle, Robin Hume, M.S., Joseph Massaro, Ph.D., Alison L. Hannah, MD, Massimo Iacobelli, MD, Paul G Richardson, Defibrotide Study Group

Blood (2010) 116 (21): 3482.

https://doi.org/10.1182/blood.V116.21.3482.3482

Published: 2010

Journal Articles

The Oral Iron Chelator Deferasirox for Treatment of Transfusional Iron Overload After Allogeneic Hematopoietic Cell Transplantation Does Not Appear to Interfere with the Calcineurin Inhibitor Cyclosporin Trough Serum Levels

Haifa Kathrin Al-Ali, MD, Nadja Jaekel, MD, Alexia Nass, Sandra Otto, Gesine Bug, Nicolaus Kroeger, Uwe Platzbecker, Michael Stadler, MD, Katharina de Haas, MD, Dietger W Niederwieser, MD

Blood (2010) 116 (21): 1826.

https://doi.org/10.1182/blood.V116.21.1826.1826

Published: 2010

Journal Articles

Successful Mobilization of Peripheral Blood Stem Cells After Intensive Bendamustine Pre-Treatment In Patients with Multiple Myeloma

Wolfram Pönisch, Julia Wiesler, Sabine Leiblein, Elvira Edel, Haifa K. Al-Ali, Nadezda Basara, MD, Ute Hegenbart, Christiane Heiß, Dietger W Niederwieser, MD, Hartmut Goldschmidt

Blood (2010) 116 (21): 4439.

https://doi.org/10.1182/blood.V116.21.4439.4439

Published: 2010

Journal Articles

Matched Unrelated Donor Transplantation Is Curative In Selected Patients with Diffuse Large B Cell Lymphoma: A Report of the Lymphoma Working Party (LWP) of the European Group for Blood and Marrow Transplantation (EBMT)

Irit Avivi, MD, Carmen Canals, Jian Jian Luan, Gerald. G. Wulf, Arnon Nagler, M.D., Agnes Buyzin, Eefke J. Petersen, MD, PhD, Jean-Pierre Jouet, MD, Donald Milligan, MD, FRCP, FRCPath, Anton Schattenberg, MD, Dietger W Niederwieser, MD, Kirsty Thomson, Didier Blaise, MD, Michel Attal, Gerhard Held, MD, Peter Dreger, MD, PhD, Anna Sureda, MD, PhD

Blood (2010) 116 (21): 363.

https://doi.org/10.1182/blood.V116.21.363.363

Published: 2010

Journal Articles

The Ratio of Pre-Transplant Serum Ferritin to the Units of Blood Transfused and Not Serum Hepcidin Strongly Correlates with Outcome After Allogeneic Hematopoietic Cell Transplantation In Patients with AML and MDS.

Haifa Kathrin Al-Ali, MD, Nadja Jaekel, MD, Rainer Krahl, MD, Elvira Edel, Claudia Wickenhauser, Mark Westerman, Sabine Leiblein, Uwe Gerd Liebert, Marianne Hehme, Dietger W Niederwieser, MD

Blood (2010) 116 (21): 1307.

https://doi.org/10.1182/blood.V116.21.1307.1307

Published: 2010

Journal Articles

High Levels of Nm23-H2 Protein Are a Specific and Invariable Feature of CML-CP Cells Due to Post Transcriptional Control Via a Bcr-Abl Dependent Pathway

Sabine Tschiedel, Michael Cross, Enrica Müller, Annette Jilo, Song-Yau Wang, Vladan ucinic, Thoralf Lange, MD, Haifa Kathrin Al-Ali, MD, Dietger W Niederwieser, MD

Blood (2010) 116 (21): 4461.

https://doi.org/10.1182/blood.V116.21.4461.4461

Published: 2010

Journal Articles

Acute Myeloid Leukemia (AML): Prospective Comparison of Different Treatments with a Common Standard Treatment - A Study by the German AML Intergroup

Thomas Buchner, MD, Richard F. Schlenk, MD, Markus Schaich, MD, Konstanze Döhner, MD, Rainer Krahl, MD, J\)rgen Krauter, MD, Maria Cristina Sauerland, MSc, Daniela Späth, Michael Kramer, Arnold Ganser, MD, Dietger W Niederwieser, MD, Gerhard Ehninger, MD, Wolfgang E. Berdel, MD, Wolfgang Hiddemann, MD, Hartmut Dohner, MD, Dieter Hoelzer, MD, R\)diger Hehlmann, MD, Verena Hoffmann, MA., Markus Pfirrmann, PhD

Blood (2010) 116 (21): 2175.

https://doi.org/10.1182/blood.V116.21.2175.2175

Published: 2010

Journal Articles

Combined Bendamustine, Prednisolone and Lenalidomide (RBP) In Refractory or Relapsed Multiple Myeloma. First Results of a Phase I Clinical Trial

Wolfram Pönisch, Simone Heyn, Ina Wagner, Martin Mohren, MD, Franz-Albert Hoffmann, Frank Schüler, Marion Schmalfeld, Haifa K. Al-Ali, Nadja Jäkel, Dietger W Niederwieser, MD

Blood (2010) 116 (21): 1971.

https://doi.org/10.1182/blood.V116.21.1971.1971

Published: 2010

Journal Articles

Bortezomib(Velcade®)-Thalidomide-Dexamethasone (VTD) Is Superior to Thalidomide-Dexamethasone (TD) In Patients with Multiple Myeloma (MM) Progressing or Relapsing After Autologous Transplantation

Blood (2010) 116 (21): 3043.

https://doi.org/10.1182/blood.V116.21.3043.3043

Published: 2010

Journal Articles

Autologous Hematopoietic Stem Cell Transplantation (autoHSCT) in CLL: First Results of An EBMT Randomized Trial Comparing Autotransplant Versus Wait and Watch.

Mauricette Michallet, MD, PhD, Peter Dreger, MD, PhD, Laurent Sutton, MD, Ronald Brand, Sue Richards, Anja van Biezen, Mohamad Sobh, Pharm.M, Alois Gratwohl, MD, Karin Kolbe, MD, Claire E. Dearden, MD, Michael Hallek, T. M. de Witte, MD, PhD, Dietger W. Niederwieser, MD, Michel Leporrier, MD, Donald Milligan, MD

Blood (2009) 114 (22): 877.

https://doi.org/10.1182/blood.V114.22.877.877

Published: 2009

NARROW

Impact-AML: A European Master Framework for Cohort Studies and Pragmatic Clinical Trials in Relapse or Refractory Acute Myeloid Leukemia

Impact of Age on Outcome in Newly Diagnosed Multiple Myeloma Patients Undergoing Upfront Autologous Hematopoietic Cell Transplantation from the Worldwide Network for Blood and Marrow Transplantation Global Study

Help for Ukrainian Hematology Patients (HUP) - a Global Initiative Supporting the Establishment of Hematology Centers and Hematopoietic Cell Transplantation Programs in a Time of War

Changes in Cardiovascular Magnetic Resonanse T1 and T2 Mapping in Patients Undergoing Autologous Hematopoietic Stem Cell Transplantation

MiR-143 Targets ERK5 in Granulopoiesis and Predicts Outcome of Patients with Acute Myeloid Leukemia

Life Expectancy in Long-Term Survivors Transplanted for Myelofibrosis: A Registry Study from the Chronic Malignancies Working Party of the European Society for Blood and Marrow Transplantation

Long-Term Outcome of Allogeneic Stem Cell Transplantation (allo-SCT) in Patients with Waldenstrom Macroglobulinemia (WM)-a Retrospective Study of the Lymphoma Working Party of the European Society for Blood and Marrow Transplantation (EBMT)

Randomized Controlled Trial of Two Different Dosing Regimens of Palifermin to Prevent Mucositis In Multiple Myeloma Patients Receiving One-Day Administration of High-Dose Melphalan

Outcomes Following Relapse of Non-Hodgkin Lymphoma (NHL) or Chronic Lymphocytic Leukemia (CLL) After Nonmyeloablative Conditioning and Allogeneic Hematopoietic Cell Transplantation (HCT) From HLA-Matched Related or Unrelated Donors

Allogeneic and Autologous Transplantation In Patients with Aggressive B- and T-Cell Lymphomas

Safety of Defibrotide (DF) In Stem Cell Transplant (SCT) Patients (Pts).

The Oral Iron Chelator Deferasirox for Treatment of Transfusional Iron Overload After Allogeneic Hematopoietic Cell Transplantation Does Not Appear to Interfere with the Calcineurin Inhibitor Cyclosporin Trough Serum Levels

Successful Mobilization of Peripheral Blood Stem Cells After Intensive Bendamustine Pre-Treatment In Patients with Multiple Myeloma

Matched Unrelated Donor Transplantation Is Curative In Selected Patients with Diffuse Large B Cell Lymphoma: A Report of the Lymphoma Working Party (LWP) of the European Group for Blood and Marrow Transplantation (EBMT)

The Ratio of Pre-Transplant Serum Ferritin to the Units of Blood Transfused and Not Serum Hepcidin Strongly Correlates with Outcome After Allogeneic Hematopoietic Cell Transplantation In Patients with AML and MDS.

High Levels of Nm23-H2 Protein Are a Specific and Invariable Feature of CML-CP Cells Due to Post Transcriptional Control Via a Bcr-Abl Dependent Pathway

Acute Myeloid Leukemia (AML): Prospective Comparison of Different Treatments with a Common Standard Treatment - A Study by the German AML Intergroup

Combined Bendamustine, Prednisolone and Lenalidomide (RBP) In Refractory or Relapsed Multiple Myeloma. First Results of a Phase I Clinical Trial

Bortezomib(Velcade®)-Thalidomide-Dexamethasone (VTD) Is Superior to Thalidomide-Dexamethasone (TD) In Patients with Multiple Myeloma (MM) Progressing or Relapsing After Autologous Transplantation

Autologous Hematopoietic Stem Cell Transplantation (autoHSCT) in CLL: First Results of An EBMT Randomized Trial Comparing Autotransplant Versus Wait and Watch.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only